IAM writes about Burford Capital's work with Colibri Heart Valve

IAM reports that Burford’s work with Colibri Heart Valve, which resulted in a $106.6 million verdict against Medtronic, provides an example of a small medical device company using litigation funding to win an infringement verdict against a huge rival, countering the narrative that litigation funders are fueling abusive patent litigation from non-practicing entities who are demanding huge sums from American innovators.

More from IAM (full article paywalled).